A股異動 | 揚農化工(600486.SH)逼近漲停 控股股東擬由揚農集團變更為先正達集團
格隆匯11月9日丨揚農化工(600486.SH)高開上漲,盤初一度衝擊漲停,高見102.14元創歷史新高。暫成交1.45億元,總市值309億元。揚農化工11月6日公佈,中化國際擬向先正達集團收購其持有的揚農集團39.88%的股權,同時,公司控股股東揚農集團擬向先正達集團出售其持有的公司36.17%的股份。此次交易完成後,公司將合計持有揚農集團79.88%股權,同時揚農集團不再直接持有揚農化工股份,揚農化工的控股股東將變更為先正達集團。興業證券日前指出,公司掌握核心技術雄踞全球龍頭,EPA重批麥草畏登記證或釋放需求。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.